Panadol Junior 60 mg
Panadol Junior 60 mg is a medicine authorised by Swissmedic under authorisation number 57454. The authorisation holder is Haleon Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 07 September 2006 and the authorisation is valid without a time limit. ATC code N02BE01 places the medicine in the group Analgesics.
| Authorisation number | 57454 |
|---|---|
| Name | Panadol Junior 60 mg |
| Full name | Panadol Junior 60 mg, Suppositorien |
| Authorisation holder | Haleon Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | N02BE01 |
| First authorisation | 07 September 2006 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Panadol Junior 60 mg, Suppositorien | D | 07 September 2006 |
| 2 | Panadol Junior 125 mg, Suppositorien | D | 07 September 2006 |
| 3 | Panadol Junior 250 mg, Suppositorien | D | 07 September 2006 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 3 | 10 | Suppositorien | N02BE01 | 01.01.1. | D |
| 9 | 10 | Suppositorien | N02BE01 | 01.01.1. | D |
| 21 | 10 | Suppositorien | N02BE01 | 01.01.1. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Panadol Junior 60 mg authorised in Switzerland?
Yes. Panadol Junior 60 mg is authorised by Swissmedic under authorisation number 57454, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Panadol Junior 60 mg have?
Panadol Junior 60 mg is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Panadol Junior 60 mg?
The authorisation holder is Haleon Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.